Waldron Private Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,238
Closed -$914K 310
2024
Q4
$914K Buy
10,238
+5,140
+101% +$452K 0.04% 181
2024
Q3
$427K Buy
5,098
+152
+3% +$12K 0.02% 274
2024
Q2
$381K Sell
4,946
-258
-5% -$18.9K 0.02% 274
2024
Q1
$356K Buy
5,204
+159
+3% +$10.2K 0.02% 282
2023
Q4
$292K Buy
5,045
+600
+13% +$32K 0.01% 316
2023
Q3
$235K Buy
4,445
+102
+2% +$5.35K 0.01% 327
2023
Q2
$235K Sell
4,343
-129
-3% -$6.74K 0.01% 333
2023
Q1
$224K Buy
+4,472
New +$211K 0.01% 373

Other funds holding BSX

Waldron Private Wealth's BSX Position: Q1 2025 in Review

Waldron Private Wealth sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 10,238 shares — an estimated $914K sold.

Waldron Private Wealth first reported a position in BSX in Q1 2023 and held it in 8 quarters. The position peaked at $914K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Waldron Private Wealth reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Waldron Private Wealth sold 10,238 Boston Scientific shares in Q1 2025, an estimated $914K.
  • Waldron Private Wealth first reported a position in Boston Scientific in Q1 2023 and held it in 8 quarters.
  • Waldron Private Wealth's Boston Scientific position peaked at $914K in Q4 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Waldron Private Wealth's 13F filing for Q1 2025, filed 8 May 2025.